Skip to main content
EW logo
EW
(NYSE)
Edwards Lifesciences Corporation
$81.05-- (--)
Loading... - Market loading

Edwards Lifesciences Corporation (EW) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Edwards Lifesciences Corporation stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Strong Buy
Based on 9 unique analysts
(11 total ratings in last 90 days)
Medium Confidence:1 Buy/Sell

Average Price Target

$99.22
22.42% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest EW Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Adam Maeder
Piper Sandler
BuyReiterates
$98.00 $100.00
Marie Thibault
BTIG
Strong BuyReiterates
$103.00 $103.00
Richard Newitter
Truist
HoldMaintains
$92.00 $89.00
David Roman
Goldman Sachs
Strong BuyMaintains
$108.00 $95.00
Larry Biegelsen
Wells Fargo
BuyMaintains
$96.00 $100.00
Rick Wise
Stifel
Strong BuyMaintains
$105.00 $110.00
Adam Maeder
Piper Sandler
BuyMaintains
$95.00 $98.00
Matt Miksic
Barclays
BuyMaintains
$103.00 $104.00
Danielle Antalffy
UBS
HoldMaintains
$92.00 $95.00
Joshua Jennings
TD Cowen
Strong BuyUpgrades
$90.00 $97.00
Rick Wise
Stifel
Strong BuyMaintains
$100.00 $105.00

Frequently Asked Questions

What is the analyst consensus rating for EW?

The analyst consensus rating for EW is "Strong Buy" based on 9 analyst recommendations.

What is the average price target for EW?

The average 12-month price target for EW is $99.22, representing an upside of 22.4% from the current price of $81.05.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.